DOJ Probing Par Over Megace Off-Label Marketing
The U.S. Department of Justice has launched an investigation into Par Pharmaceutical Cos. Inc.'s promotional practices for its appetite enhancer Megace ES, the drugmaker said in a regulatory filing....To view the full article, register now.
Already a subscriber? Click here to view full article